Terms: = Breast cancer AND CD52, CDW52, EDDM5 AND Treatment
5 results:
1. cd52 mRNA expression predicts prognosis and response to immune checkpoint blockade in melanoma.
de Vos-Hillebrand L; Fietz S; Hillebrand P; Kulcsár Z; Diop MY; Hollick S; Maas AP; Strieth S; Landsberg J; Dietrich D
Pigment Cell Melanoma Res; 2024 Mar; 37(2):309-315. PubMed ID: 37975535
[TBL] [Abstract] [Full Text] [Related]
2. Immunophenotype-associated gene signature in ductal breast tumors varies by receptor subtype, but the expression of individual signature genes remains consistent.
Behring M; Ye Y; Elkholy A; Bajpai P; Agarwal S; Kim HG; Ojesina AI; Wiener HW; Manne U; Shrestha S; Vazquez AI
Cancer Med; 2021 Aug; 10(16):5712-5720. PubMed ID: 34189853
[TBL] [Abstract] [Full Text] [Related]
3. Autologous Natural Killer Cell-enrichment for Immune Cell Therapy: Preclinical Setting Phase, Shiraz Experience.
Rezaeifard S; Heike Y; Masuyama JI; Rezvani A; Vojdani R; Erfani N
Iran J Allergy Asthma Immunol; 2021 Apr; 20(2):233-243. PubMed ID: 33904681
[TBL] [Abstract] [Full Text] [Related]
4. [New immunological weapons for medicine in the 21st Century: biological therapy based on the use of the latest generation monoclonal antibodies].
Aguillón JC; Contreras J; Dotte A; Cruzat A; Catalán D; Salazar L; Molina MC; Guerrero J; López M; Soto L; Salazar-Onfray F; Cuchacovich M
Rev Med Chil; 2003 Dec; 131(12):1445-53. PubMed ID: 15022409
[TBL] [Abstract] [Full Text] [Related]
5. Monoclonal antibodies in human cancer.
Mellstedt H
Drugs Today (Barc); 2003; 39 Suppl C():1-16. PubMed ID: 14988743
[TBL] [Abstract] [Full Text] [Related]
